Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22691757

Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Gynecol Oncol
Publication date
2012 Sep
First author
Dueňas-González A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Dueňas-González A
      type
      Author
    2. name
      Orlando M
      type
      Author
    3. name
      Zhou Y
      type
      Author
    4. name
      Quinlivan M
      type
      Author
    5. name
      Barraclough H
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Dueňas-González A
      type
      Author
    2. name
      Orlando M
      type
      Author
    3. name
      Zhou Y
      type
      Author
    4. name
      Quinlivan M
      type
      Author
    5. name
      Barraclough H
      type
      Author
    bibliography ids
    1. nci-bib-8d0756a7ef8560cc99888336
    book metadata
    content sha256
    8d0e4a841a914c1a01a7e2e3943521b956c20c39b077c8129275acaf87e75dad
    document type
    citation
    dois
    1. 10.1016/j.ygyno.2012.06.011
    electronic publication date
    display
    2012 Jun 9
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:22691757
    immutable id
    pubmed:22691757@8d0e4a841a914c1a01a7e2e3943521b956c20c39b077c8129275acaf87e75dad
    journal
    abbreviation
    Gynecol Oncol
    issn electronic
    1095-6859
    issn print
    0090-8258
    issue
    3
    name
    Gynecologic oncology
    nlm unique id
    0365304
    pages
    334-40
    volume
    126
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      22691757
      provenance
      batch id
      c95be1d0b8cf19942816
      provider
      NCBI PubMed ESummary
      record sha256
      c010b14eb16c11966344ae1911ef4c9662d5698c18aabefcd7d6c409175dcd1c
      response sha256
      a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
      retrieved at
      2026-09-09T23:46:47.691937+00:00
      publication date
      display
      2012 Sep
      precision
      month
      year
      2012
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/22691757/
      title
      Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial.

      Preserved source evidence · Not medical advice